Davis Polk & Wardwell is advising Gilead Sciences, Inc. on the transaction, and Cravath, Swaine & Moore is advising CymaBay Therapeutics, Inc. Gilead Sciences, Inc. (Gilead)...
Gilead Sciences’ $4.3 Billion Acquisition of CymaBay Therapeutics
Intuit’s $4 Billion Notes Offering
Gibson, Dunn & Crutcher advised Intuit Inc., and Davis Polk & Wardwell advised the representatives of the underwriters in the offering. Intuit Inc. (Nasdaq:INTU) announced its $750...
Vishay Intertechnology’s $750 Million Convertible Senior Notes Offering
Davis Polk & Wardwell advised the representative of the initial purchasers on the offering. Vishay Intertechnology, Inc. (NYSE: VSH) announced it has completed its offering of $750 million aggregate...
AN2 Therapeutics’ $70 Million Common Stock Offering
Cooley advised AN2 Therapeutics, Inc., and Davis Polk & Wardwell advised the joint book-running managers on the offering. AN2 Therapeutics, Inc. (Nasdaq:ANTX) announced a SEC-registered follow-on...
Recursion Pharmaceuticals’ $300 Million At-The-Market Offering
Wilson Sonsini Goodrich & Rosati advised Recursion Pharmaceuticals, Inc.; and Davis Polk & Wardwell LLP advised Jefferies LLC, as sales agent, in the offering. Recursion Pharmaceuticals,...
Upgrade’s $100 Million Acquisition of Uplift
Davis Polk & Wardwell advised Upgrade, Inc. on the transaction. Upgrade, Inc. announced the acquisition of Uplift, Inc., the leading provider of Buy Now Pay Later (BNPL)...
AN2 Therapeutics’ $100 Million At-The-Market Offering
Cooley advised AN2 Therapeutics on the offering, and Davis Polk advised the sales agent. AN2 Therapeutics, Inc. announced the SEC-registered at-the-market offering of its common stock...
Mirion Technologies’ $85.6 Million Secondary Offering
Goodwin Procter advised Mirion Technologies on the offering, and Davis Polk advised the underwriter. Mirion Technologies announced the $85.6 million offering of 9,786,153 shares of its Class...
Mirion Technologies’ $150 Million Direct Offering of Common Stock
Davis Polk advised Mirion Technologies on the offering. Mirion Technologies, Inc. announced a registered direct offering of 17,142,857 shares of its Class A common stock at...
RxSight’s $50 Million Common Shares Offering
Wilson Sonsini advised RxSight, and Davis Polk advised the sole bookrunning manager in the offering. RxSight, Inc. announced a $50 million SEC-registered follow-on offering of 4,000,000...
EDAP TMS’s $23 Million Follow-on Offering
Davis Polk represented Jefferies LLC, the sole book-running manager, in the offering. EDAP TMS S.A. executed $23 million public offering of 3,066,667 American Depositary Shares (which includes...
Bloom Energy’s $338 Million Shares Offering
Latham & Watkins represented Bloom Energy in the transaction, while Davis Polk advised the underwriters. Bloom Energy Corporation (NYSE: BE), the developer of a solid-oxide platform for...